Outcome of Patients Receiving Radiation for Cancer of the Esophagus: Results of the 1992-1994 Patterns of Care Study PURPOSE: Anticancer drugs may induce acute mucosal injury to stomach and duodenum.
MedPage Today on MSN
After 5 Years, Acid-Reducer Is Back on the Market
The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled ...
NEW YORK, July 31 (Praxis Press) Previous studies have shown that omeprazole sodium is more effective than ranitidine hydrochloride in controlling symptoms of heartburn in patients with ...
The bad news for heartburn sufferers, of course, is that Zantac and its ranitidine generics have, perhaps for years, contained a suspected carcinogen without the FDA knowing it. The good news is that ...
Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.
Washington — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a ...
If you go to your local pharmacy or convenience store, you won’t be able to find any Zantac or other products made out of ranitidine. At least, you shouldn’t. But it’s not because people are hoarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results